ce
The NIOSH Hazardous Drug List
floxuridine fludarabine fluorouracil
Antineoplastic agents Antineoplastic agents
Yes Yes Yes
No No No
Antineoplastic agents; skin and mucous membrane agents, miscellaneous Nucleosides and nucleotides; antivirals
ganciclovir
Yes
No
Gemtuzumab ozogamicin Antineoplastic agents
Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes
Yes
hydroxyurea
Antineoplastic agents Antineoplastic agents Antineoplastic agents Antineoplastic agents Antineoplastic agents Antineoplastic agents Antineoplastic agents Antineoplastic agents
No No No No
idarubicin ifosfamide
imatinib
inotuzumab ozogamicin irinotecan ixabepilone
Yes
No No No No
ixazomib
lenalidomide
Antineoplastic agents, immu- nomodulatory agents
loncastuximab tesirine
Antineoplastic agents
Yes
Yes
lomustine
Antineoplastic agents Antineoplastic agents
Yes Yes Yes
No No No
IARC Group 2A carcinogen
lurbinectedin
mechlorethamine
Antineoplastic agents; skin and mucous membrane agents
melphalan
Antineoplastic agents
Yes
No
IARC Group 1 carcinogen; NTP “known to be a human carcinogen”
melphalan flufenamide
Antineoplastic agents
Yes Yes
No No
mercaptopurine
Antineoplastic agents; immu- nosuppressive agents Antineoplastic agents; im- munomodulatory agents; dis- ease-modifying antirheumatic drugs; immunosuppressive agents Antineoplastic agents; immu- nosuppressive agents
methotrexate
Yes
No
mirvetuximab
Yes
No
soravtansine
Antineoplastic agents Antineoplastic agents Antineoplastic agents Antineoplastic agents
Yes Yes Yes Yes
Yes
mitomycin mitotane
No No No No No No No No
IARC Group 2B*
mitoxantrone
IARC Group 2B*
mycophenolate mofetil
Immunosuppressive agents Yes
oxaliplatin paclitaxel
Antineoplastic agents Antineoplastic agents Antineoplastic agents Antineoplastic agents
Yes Yes Yes Yes
panobinostat pemetrexed
CPhT CONNECT
www.cphtconnect.com 38
Made with FlippingBook - PDF hosting